SCHEMBL6869683

SCHEMBL6869683

CC(C)NC(=N)c1ccc2[nH]c(CCc3nc4cc(C(=N)NC(C)C)ccc4[nH]3)nc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
MAPK1 P28482 1/20 0.41
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39
F10 P00742 6/20 0.39
TPSAB1 Q15661 3/20 0.39
PRSS1 P07477 2/20 0.39
F2 P00734 2/20 0.39
PLG P00747 1/20 0.39
PLAU P00749 1/20 0.39
PRSS2 P07478 1/20 0.39
PRSS3 P35030 1/20 0.39
TPSD1 Q9BZJ3 1/20 0.38
TPSG1 Q9NRR2 1/20 0.38
F7 P08709 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HTT P42858 1/20 0.36
APEX1 P27695 1/20 0.36
KLK1 P06870 1/20 0.36
KLK5 Q9Y337 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6880977 0.92 F10 (0.48) ALDH1A1F10TPSAB1PRSS1F2
SCHEMBL9100846 0.91 DDAH1 (0.44) ALDH1A1MAPK1F10TPSAB1PRSS1
SCHEMBL6879854 0.81 MAPT (0.42) ALDH1A1KMT2AHDAC6HTTNPC1
SCHEMBL6879873 0.81 MAPT (0.42) ALDH1A1KMT2AHDAC6HTTNPC1
Hydrochloric Acid SCHEMBL11298541 0.80 HDAC6 (0.44) ALDH1A1POLBKMT2APRSS1PLAU
SCHEMBL549168 0.78 HDAC6 (0.39) ALDH1A1POLBKMT2AF10PRSS1
SCHEMBL548419 0.77 F10 (0.63) F10TPSAB1PRSS1F2PLG
SCHEMBL9028427 0.74 F10 (0.48) ALDH1A1F10TPSAB1PRSS1F2
SCHEMBL8677635 0.74 ALDH1A1 (0.47) ALDH1A1MAPK1POLBKMT2AF10
SCHEMBL7483538 0.74 F10 (0.44) ALDH1A1MAPK1F10TPSAB1PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6815461-B1 ADMINISTERING BIS-BENZIMIDAZOLE COMPOUND; TREATING HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2004-11-09 US disclosed
EP-0739202-B1 USE OF BIS(AMIDINOBENZIMIDAZOLES) IN THE MANUFACTURE OF MEDICAMENT FOR INHIBITING RETROVIRAL INTEGRASE UNIV NORTH CAROLINA (US) 1998-12-16 EP disclosed